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Introduction: Transglutaminase 2 (TG2), a protein crosslinking enzyme with multiple biochemical functions, has
been connected to various inflammatory processes. In this study, the involvement of TG2 in monosodium urate
(MSU) crystal-induced inflammation was studied.
Methods: Immunohistochemistry, reverse transcription-polymerase chain reaction (RT-PCR) were performed to
detect TG2 expression in synovial fluid mononuclear cells (SFMCs) and synovial tissue from patients with gouty
arthritis. MSU crystal-exposed RAW264.7 mouse macrophages were analyzed for interleukin-1β (IL-1β), tumor
necrosis factor-α (TNF-α), transforming growth factor β1 (TGF-β1) and TG2 expression by RT-PCR and enzyme-linked
immunosorbent assay (ELISA). TG2 small interfering (si)-RNA-mediated silencing and overexpression in RAW264.7
cells were used to evaluate the involvement of TG2 in resolving MSU crystal-induced inflammation. The role of
metastatic tumor antigen 1 (MTA1), a master chromatin modifier, was investigated by MTA1 si-RNA-mediated
knockdown. In addition, the inflammatory responses were followed in wild type and TG2 null mice after being
challenged with MSU crystals in an in vivo peritonitis model.
Results: TG2 expression was up-regulated in the synovium tissue and SFMCs from patients with gouty arthritis.
The levels of MTA1, TG2, TGF-β1, IL-1β and TNF-α mRNAs were consistently increased in MSU crystal-stimulated
RAW264.7 cells. si-MTA1 impaired the basal, as well as the MSU crystal-induced expression of TG2 and TGF-β1,
but increased that of IL-1β and TNF-α. TG2 overexpression dramatically suppressed MSU crystal-induced IL-1β
and TNF-α, but significantly enhanced the TGF-β1 production. Neutralizing TGF-β antibodies or inhibition of the
crosslinking activity of TG2 attenuated these effects. On the contrary, loss of TG2 resulted in a reduced TGF-β, but
in an increased IL-1β and TNF-α production in MSU crystal-stimulated RAW264.7 cells and mouse embryonic
fibroblasts (MEFs). MSU crystal-stimulated IL-1β production was Janus kinase 2 (JAK2)-signaling dependent and
TG2-induced TGF-β suppressed the activity of it. Finally, TG2-deficient mice exhibited hyper inflammatory responses
after being challenged with MSU crystals in an in vivo peritonitis model.
Conclusions: These findings reveal an inherent regulatory role of the MTA1-TG2 pathway in the self-limitation of
MSU crystal-induced inflammation via positively regulating the levels of active TGF-β1 in macrophages that opposes
the MSU crystal-induced JAK2-dependent pro-inflammatory cytokine formation.* Correspondence: gjt@csmu.edu.tw
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Gouty arthritis (GA) is a characteristically intense acute
inflammatory reaction, which is initiated by precipitation
of monosodium urate (MSU) crystals [1]. An attack of is a
paradigm for acute sterile self-limited inflammation that is
triggered by interactions between MSU microcrystals and
the local tissue environment [2]. Our current understand-
ing suggests that resident cells with such tissues, such as
resident macrophages or monocytes, react first to crystal
deposition by uptake of crystals through phagocytosis [3].
Through a series of steps that are still not well-understood,
these phagocytes activate the NLRP3 inflammasome,
resulting in the activation of caspase-1 and processing and
secretion of IL-1β [4]. IL-1β then acts primarily on non
bone-marrow-derived cells, such as capillary endothelial
cells, by triggering MyD88-dependent events [5,6]. Experi-
mental data on various knockout mice [7] and the rapid
clinical response of patients with acute GA to IL-1 inhib-
ition [8] validate the concept that IL-1 plays a key role in
the initiation of gouty inflammation.
Besides IL-1β, uptake of MSU crystals by phagocytes
also triggers the production of the pro-inflammatory cyto-
kine IL-6 [9] and TNF-α [10], as well as that of the anti-
inflammatory transforming growth factor β (TGF-β1) [11].
It was suggested that TGF-β1, a powerful inhibitor of
inflammation [12], is involved in the resolution of gouty
inflammation in experiments, in which administration of
recombinant TGF-β1 attenuated MSU crystal-induced in-
flammation in an in vivo air-pouch model [13], and be-
cause of the observation that upregulation of TGF-β1 is
strongly associated with the rapid resolution of acute GA
[14,15]. TGF-β1 significantly inhibits leukocyte infiltration
into air pouches injected with MSU crystals [13], and
suppresses monocyte pro-inflammatory cytokine release
in response to MSU crystals, endothelial cell activation in
response to monocyte-derived cytokines, and macrophage
release of TNF-α. In addition, this growth factor may
contribute to fibroblast proliferation and the physical
encasing of crystals away from contact with leukocytes
[16]. TGF-β1 is normally secreted as part of a protein
complex, which associates on the cell surface with αv-
containing integrins [17,18]. TGF-β1 can be activated
by the proteolysis of latency-associated peptide-β1 lead-
ing to the release of free TGF-β1 [19]. Transglutaminase
2 (TG2), which acts as a co-receptor for αvβ1 and β3
integrins [20], has been suggested to contribute to TGF-
β1 activation by bringing latency-associated peptide-β1
and the proteolytic activity on the macrophage cell sur-
face into close proximity [17,21].
TG2 is a unique member of an enzyme family, because
in addition to its protein cross-linking activity, it can act
also as a G protein or co-receptor for the β1 and β3
integrins [22,23]. TG2 in macrophages has been shown
to require the metastatic tumor antigen 1 (MTA1), aubiquitously expressed chromatin modifier that regulates
transcription of its targets by modifying the acetylation
status of the target chromatin and the consequent co-
factor accessibility to the target DNA, both for its basal
and lipopolysaccharide-induced expression [24]. TG2,
found both extracellularly at the cell surface in associ-
ation with the extracellular matrix, and intracellularly in
membrane-associated as well as in cytosolic forms, has
been implicated in a variety of cellular processes including
phagocytosis of apoptotic cells by macrophages [25,26]. By
being involved in the clearance of apoptotic neutrophils
by macrophages, TG2 has been suggested to limit GA via
promoting the resolution phase of inflammation [27].
In the present paper we propose that TG2 might limit
GA also by participating in the initiation phase of the
disease, in which TG2 expressed at higher levels on the
surface of MSU crystal-exposed macrophages enhances
MSU crystal-induced TGF-β1 production which, in




MSU crystals were prepared as described previously [5].
Briefly, 5 mg/ml uric acid (Sigma, St Louis, MO, USA)
was dissolved in 0.1 M Borate buffer (Ph 8.5) and added
NaOH to keep the pH between 8.5 and 9.0. The solution
was cleaned of any undissolved solid using a 0.45-m filter.
The crystals came out of solution within 24 hours and
then the precipitation continued for about a week. Finally,
the crystals were washed twice in the centrifuge with ab-
solute alcohol and then once with acetone. Needle-like
crystals were recovered and were suspended in sterile sa-
line. Recombinant mouse TG2 and mouse IgG isotype
control were purchased from R&D Systems (Minneapolis,
MN, USA).
Sample collection
Synovial fluid was collected from the swollen knee joints
of 16 patients with GA in acute phase, who were receiving
uricosuric agents including allopurinol and benzbromar-
one, 5 patients with rheumatoid arthritis and 20 patients
with osteoarthritis. The synovial fluid white blood cell
(WBC) count of the 16 patients with gouty arthritis were
between 2.5 and 61.8 K/uL (mean 25.2 K/uL). Synovial tis-
sue (ST) specimens were collected from patients with GA
at knee arthroscopy, from healthy individuals who had ex-
perienced traffic accidents, and patients with osteoarthritis
during total knee replacement. Needle-shaped MSU
crystals were detected intracellularly and extracellularly
in synovial fluid by polarized light microscopy. All sub-
jects gave written informed consent, and the study has
been approved by the Institutional Review Board of the
Chung Shan Medical University Hospital. Diagnosis of
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toid arthritis [30] conformed to the current American
College of Rheumatology criteria.
Cell culture and isolation
The murine macrophage cell line RAW264.7 was pur-
chased from Bioresource Collection and Research Center
(Hsinchu, Taiwan). Mouse embryonic fibroblast deficient
in TG2 (TG2-KO MEF cells) and wild type (WT) MEF
cells were generous gifts provided by Dr. Mauro Piacentini.
All cells were grown in DMEM (Gibco/BRL, Grand
Island, NY, USA) containing 10% fetal bovine serum
(Biological Industries, Kibbutz Beit Haemek, Israel) and
1% Pen-Step Ampho. Solutionb (Biological Industries).
Monocyte-derived macrophages (MDMs) were isolated
from peripheral blood mononuclear cells (PBMCs) by plas-
tic adherence. Phenotypical and functional characterization
of MDMs was performed after 6 to 7 days. Synovial fluid
mononuclear cells (SFMCs) were isolated from 16 patients
with GA, 5 patients with rheumatoid arthritis and 20 pa-
tients with osteoarthritis using Ficoll-Hypaque gradient
(Sigma-Aldrich). PBMCs isolated from five healthy donors
served as normal controls.
Treatment with MSU crystals
Treatment with MSU crystals was performed at 37°C at
concentrations of 1 mg/ml for RAW264.7 cells, PBMCs
and MDMs, and 2 mg/ml for MEF cells for the indicated
time periods, because we found that 1 mg/ml of MSU
crystals is sufficient to induce cytokine production in
RAW264.7 cells, PBMCs and MDMs, but not enough to
do so in MEF cells. In the initial experiments, a significant
increase in IL-1β and TGF-β1 mRNA expression was evi-
dent as early as 30 minutes after MSU crystals challenge,
which reached its peak at 4 h. That is why many of the ex-
periments were carried out at this time point. None of the
doses of MSU crystals used in the experiments induced cell
death within 48 h, as examined by Annexin V-FITC and PI
staining(AbD Serotec, Oxford, UK) followed by FACSCAN
laser flow cytometry analysis (Becton Dickenson, San Jose,
CA, USA).
Immunohistochemistry
The synovial tissues were embedded in paraffin and cut
into sections. The resulting specimens were treated with
3% H2O2 for 10 minutes to block endogenous peroxidase
activity and incubated with normal horse serum (Santa
Cruz Biotechnology, Santa Cruz, CA, USA). The sections
were incubated with primary antibodies against TG2 or
isotype control IgG (Sigma) at 4°C for 24 h and then
detected using Histofine simple stain MAX PO (MULTI
or G; Nichirei, Tokyo, Japan). Subsequently color was
developed using diaminobenzidine (Dako, Carpinteria,CA, USA), and the sections were counterstained with
hematoxylin (Vector Laboratories, Burlingame, CA, USA).
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated from cells by using the Trizol re-
agent protocol (Sigma). cDNA was synthesised using M-
MLV Reverse Transcriptase (Promega, Madison, WI, USA).
PCR was performed using TaKaRa Taq™ Polymerase. Each
sample was tested in triplicate and normalized with
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as
an endogenous control. Sequences for the PCR primers are
listed in Additional file 1.
Cytokine production analysis
Cells were treated with MSU crystals or left untreated
for 36 h. After treatment, the concentrations of IL-1β,
TNF-α and TGF-β1 reaching its peak secretion in the
culture medium were determined by ELISA according
to the manufacturer’s instructions (Invitrogen, Carlsbad,
CA, USA).
Western blot analysis
The whole-cell protein lysates were size-fractionated by
10% SDS-polyacrylamide gels, and then transferred into
polyvinylidene fluoride (PVDF) membranes (Millipore,
Billerica, MA, USA). Membranes were blotted overnight
at 4°C with one of the following primary antibodies: rabbit
anti-TG2 (Thermo Fisher Scientific Inc., Waltham, MA),
mouse anti-JAK2, mouse anti-phospho-JAK2 (Millipore),
and mouse anti-beta-actin (Novus Biologicals). Blots were
then probed with appropriate secondary horseradish per-
oxidase (HRP)-conjugated secondary antibodies (Jackson
ImmunoResearch, West Grove, PA) and detected by an
ECL detection system (Millipore). Data were analyzed
using AlphaImager 2200 and densitometry analysis is
expressed as ‘Fold induction’ normalized to β-actin.
TG2 expression constructs and stable transfection
Full-length human TG2 was cloned into the pGene/V5-
HisB vectors (Invitrogen, Carlsbad, CA, USA). RAW264.7
cells were transfected with the pSwitch vectors contain-
ing the mifepristone-inducible system, and then co-
transfected with pGene/V5-HisB TG2 or pGene/V5-
HisB vector alone using TurboFect (Fermentas, St. Leon-
Rot, Germany) with several weeks of dual-select with
zeocin and hygromycin B.
siRNA treatment
siRNA was purchased from Santa Cruz Biotechnology.
Transfection was performed with TurboFect (Fermentas)
according to the manufacturer’s instructions. Cells were
then treated with MSU crystals for an additional 24 h.
Supernatants were collected for measurements of IL-1β,
TNF-α and TGF-β1 concentration using ELISA.
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In the mouse model, we followed the protocol of a pre-
vious study [27]. Wild-type and TG2-null mice fully
backcrossed onto BL57/6 background [31] were injected
intraperitoneally with 1 ml PBS containing 3 mg MSU
crystals (prepared as described earlier). During the final
preparations the MSU crystals were washed in PBS.
Injection of PBS alone had no effect on the cytokine for-
mation or the neutrophil cell number injected into wild-
type mice. Mice were sacrificed at the indicated time
points and peritoneal cells were obtained by lavage with
2 ml sterile PBS. Total cell numbers were counted and
percentage of neutrophil cells was determined by labeling
the cells with fluorescein isothiocyanate (FITC)-conju-
gated anti-GR1 (BD Biosciences) antibody. Samples were
analyzed on Becton Dickinson FACScan platform. Active
TGF-β1 and IL-1β were determined from centrifuged,
cell-free peritoneal lavage fluid by ELISA (eBioscience and
R&D Systems, respectively). Mice were maintained in
specific-pathogen-free condition in the Central Animal
Facility and all animal experiments were approved by
the Animal Care and Use Committee of University of
Debrecen (DEMÁB).
Statistics
The data were analyzed with GraphPad Prism 4 software
by one-way analysis of variance (ANOVA) or Student’s
t-test to determine the significance of differences between
sets of categorical data. Data reported were verified in at
least three different experiments and are represented as the
mean ± standard error of the mean (SEM). A P-value <0.05
was considered to be significant.
Results
TG2 expression is enhanced in synovial fluid mononuclear
cells of patients with GA and in MSU crystal-treated
human PBMCs and monocyte-derived macrophages
To investigate whether TG2 mRNA expression is altered
in human GA, we examined synovial tissues of patients
with GA by RT-PCR. Figure 1A demonstrates enhanced
TG2 mRNA expressions in 6 randomly selected SFMCs
from 16 patients with GA, as compared to that of healthy
donors or rheumatoid arthritis patients. Details on TG2
expression in SFMCs from healthy donors and patients
with GA, osteoarthritis or rheumatoid arthritis are given
in Figure 1B. Our data confirm previous observations for
the enhanced expression of TG2 in SFMCs from osteo-
arthritis patients [32] and demonstrate for the first time
the enhanced expression of TG2 in gout as well. No cor-
relation between the enhanced TG2 levels and the WBC
counts were found (data not shown). Next, we further
compared TG2 expression in the synovium of patients
suffering from either GA or osteoarthritis (Figure 1C). Im-
munohistochemistry revealed that TG2 expression waspresent in the synovial tissue sections of both types of pa-
tient; however, an overall and stronger TG2 staining was
detected in the GA synovium. In addition, in freshly iso-
lated PBMCs and MDMs, exposure to MSU crystals for
12 h resulted in a strong induction of TG2 (Figure 1D, E).
These results indicate that there is a higher TG2 expres-
sion in GA, and MSU crystals induce TG2 mRNA levels
in PBMCs and MDMs in vitro.Exposure to MSU crystals induces the expression of both
pro- and anti-inflammatory cytokines and that of TG2 in
RAW264.7 macrophages
In order to examine whether TG2, pro- and anti-
inflammatory cytokines were concomitantly induced in
MSU crystal-induced acute gout inflammation, the mRNA
expression levels of IL-1β, TNF-α, TG2 and TGF-β1 were
determined by RT-PCR in RAW264.7 macrophages stim-
ulated with different doses of MSU crystals for 4 h. We
found that mRNA levels of IL-1β, TNF-α and TG2 were
upregulated dose-dependently. TGF-β1 mRNA was mod-
estly increased by MSU crystals at a dose as low as
0.1 mg/ml and was further upregulated between 0.2 and
1.0 mg/ml (Figure 1F). TG2 protein levels were also in-
creased dose-dependently after MSU crystal exposure for
24 h (Figure 1G). Further, we analyzed the kinetics of
TG2, IL-1β, TNF-α and TGF-β1 production induced by
MSU crystals. As shown in Figure 1G, H, the amount of
TG2 detected in the macrophages and that of IL-1β, TNF-
α and TGF-β1 detected in the cell culture supernatants
was increased following 24 to 36 h after stimulation, and
decreased by 48 h. These data demonstrate that exposure
to MSU crystals concomitantly increases the expression of
IL-1β, TNF-α, TG2 and TGF-β1 in macrophages, TG2
and TGF-β1 being induced first.Knockdown or overexpression of TG2 inversely influences
MSU crystal-induced IL-1β, TNF-α and TGF-β1 production
in RAW264.7 cells
To investigate a possible influence of TG2 on cytokine
regulation in acute gouty inflammation, we performed
siRNA-mediated knockdown of TG2 in RAW264.7 cells.
After 48 h post-transfection, cells were stimulated with
MSU crystals for 4 h. As shown in Figure 2A and B, reduc-
tion in the endogenous TG2 expression by specific siRNA
in RAW264.7 cells compromised the ability of MSU crys-
tals to induce the expression of TGF-β1 mRNA, whereas
MSU crystal-induced IL-1β and TNF-α mRNA expres-
sion was enhanced as compared to non-silencing con-
trol siRNA-treated cells. In accordance with the mRNA
expressions, enhanced levels of pro-inflammatory cyto-
kines, but reduced levels of TGF-β1, were detected at
36 h in the cell culture supernatants of the TG2 silenced
cells in response to MSU crystals (Figure 2C).
Figure 1 Exposure to monosodium urate (MSU) crystals induces the expression of transglutaminase 2 (TG2) in synovial tissues of
patients with gouty arthritis (GA). (A) RT-PCR analysis of TG2 mRNA expression in synovial fluid mononuclear cells (SFMCs) from six patients
with GA, one patient with rheumatoid arthritis (RA) and one with normal PBMCs (N). (B) mRNA levels of TG2 in SFMCs of patients with gouty
arthritis (GA) (n = 16), osteoarthritis (OA) (n = 20), rheumatoid arthritis (RA) (n = 5) and in PBMCs of healthy donors (normal) (n = 5). Each point
represents an individual patient. TG2 mRNA levels are expressed in arbitrary units (horizontal lines denote median values). (C) Representative
images of immunohistochemical staining of TG2 in healthy tissue (left panel), osteoarthritis (OA) (middle panel) and GA (right panel) synovial
tissues. Strong staining for TG2 was observed in the inflammatory cell infiltrate in GA synovium (Original magnification × 200). (D-E) PBMCs (D)
and MDMs (E) isolated from healthy donors were stimulated with or without MSU crystals (1 mg/ml) for 0-12 h, and TG2 mRNA expression
was analyzed by RT-PCR. (F) Induction of IL-1β, TNF-α, TG2 and TGF-β1 mRNA expression in RAW264.7 cells stimulated with MSU crystals (0.1-1.0
mg/ml) for 4 h analyzed by RT-PCR. (G) Western blot analysis of TG2 expression in whole-cell lysates from RAW264.7 cells stimulated for 24 h
with increasing concentrations MSU crystals (0.1-1.0 mg/ml) and for the indicated time periods with 1 mg/ml MSU crystals. The ‘Fold’ induction
was measured by densitometry analysis and normalized to β-actin. (H) Cells were stimulated with or without MSU crystals (1 mg/ml). The levels
of IL-1β, TNF-α and TGF-β1 in supernatants were evaluated by ELISA at the indicated time points. The results are expressed as the means ± SEM
from three independent experiments (n≧ 3, * = P < 0.05, ** = P < 0.01 compared with control (100%)).
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expressing TG2 or an empty vector (mock). RT-PCR ana-
lysis and immunoblotting were used to confirm overex-
pression of TG2 (Figure 2D-H). We found that MSU
crystals (1 mg/ml) in TG2-overexpressing RAW264.7 cells
induced higher TGF-β1 mRNA expression than in mock
treated cells (Figure 2D and F). In contrast, TG2 overex-
pression attenuated MSU crystal-induced IL-1β and TNF-α mRNA levels (Figure 2D, G and H). In harmony with
the mRNA expressions, MSU crystal-induced TGF-β1
levels were enhanced, whereas IL-1β and TNF-α amounts
were downregulated in culture supernatants of TG2-
overexpresseing RAW264.7 cells (Figure 2I). These results
indicate that TG2 negatively and positively influences the
MSU crystal-induced pro- and anti-inflammatory cytokine
production, respectively.
Figure 2 Inverse effect of transglutaminase 2 (TG2) knockdown or overexpression on monosodium urate (MSU) crystal-induced
cytokines production in RAW264.7 cells. (A) RT-PCR analysis of IL-1β, TNF-α, TG2 and TGF-β1 mRNA expression in RAW264.7 cells transfected
first with TG2 specific small interfering RNAs (siRNAs) for 48 h, then stimulated with or without MSU crystals (1 mg/ml) for 4 h. (B) Quantification
of RT-PCR analysis of TG2, TGF-β1, IL-1β and TNF-α mRNA expressions. (C) Cells transfected with TG2-siRNA were stimulated with or without MSU
crystals (1 mg/ml) for 36 h. The levels of TGF-β1, IL-1β and TNF-α in supernatants were collected and evaluated by ELISA. Mean control value of
TGF-β1 (209.5 ± 21.2 pg/ml), IL-1β (23.1 ± 2.1 pg/ml) and TNF-α (137.8 ± 15.2 pg/ml). (D) RT-PCR analysis of IL-1β, TNF-α, TG2 and TGF-β1 mRNA
expression in RAW264.7 cells stably transfected with TG2 or empty vector (mock) stimulated with or without MSU crystals (1 mg/ml) for 4 h. (E)
Immunoblot analysis of TG2 in RAW264.7 cells stably transfected with TG2 or empty vector (mock). (F-H) Quantification of RT-PCR analysis of (F)
TGF-β1, (G) IL-1β and (H) TNF-α mRNA expression. (I) Cells transfected with TG2 or empty vector were stimulated with or without MSU crystals
(1 mg/ml) for 36 h. The levels of TGF-β1, IL-1β and TNF-α in supernatants were collected and evaluated by ELISA. The results are expressed as the
means ± SEM from three independent experiments (n≧ 3, * = P < 0.05, ** = P < 0.01 compared with control (100%)).
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TGF-β1 production in MEF cells
As siRNA-mediated knockdown studies are dependent
on the extent of target knockdown, we decided to valid-
ate the above findings by using genetically TG2-depletedMEF cells [33]. We found that TG2 deficiency substan-
tially enhanced the ability of MSU crystals to induce IL-
1β mRNA, but it suppressed the MSU crystal-induced
levels of TGF-β1 mRNA in MEF cells as well (Figure 3A).
A time-course study revealed that exposure of MEF cells
Figure 3 Cross-linking activity of transglutaminase 2 (TG2) attenuates monosodium urate (MSU) crystal-induced production of IL-1β.
(A) RT-PCR analysis of IL-1β and TGF-β1 mRNA expression in WT and TG2-KO MEF cells stimulated with or without MSU crystals (0.1-2.0 mg/ml)
for 4 h. Quantification of RT-PCR analysis of IL-1β and TGF-β1 mRNA expression is also shown. (B) Cells were stimulated with or without MSU
crystals (2 mg/ml). The levels of IL-1β and TGF-β1 in supernatants were evaluated by ELISA at the indicated time points. (C) RT-PCR analysis of
TG2, TGF-β1 and IL-1β mRNA expression in WT MEF cells stimulated with 2 mg/ml MSU crystals for the indicated time points in the presence of
30 μg/ml ZDON, an active-site inhibitor of TG2. Quantification of RT-PCR analysis of TG2, TGF-β1 and IL-1β mRNA expressions is also shown. (D)
Cells were stimulated with MSU crystals (2 mg/ml) for 36 h in the presence of increasing concentrations of ZDON. The levels of TGF-β1 and IL-1β
in supernatants were evaluated by ELISA. Mean control value of TGF-β1 (278.3 ± 18.2 pg/ml) and IL-1β (39.4 ± 5.9 pg/ml). (E) Quantification of
RT-PCR analysis for IL-1β expression in WT and TG2-KO MEF cells stimulated with or without MSU crystals (2 mg/ml) for 4 h in the presence of
increasing amounts of neutralizing anti-TGF-β1 or its isotype control antibody. (F) MEF cells were stimulated with MSU crystals (2 mg/ml) for 36 h
in the presence and absence of neutralizing TGF-β antibody. IL-1β in supernatants was evaluated by ELISA. The results are expressed as the
means ± SEM from three independent experiments (n≧ 3, * = P < 0.05, ** = P < 0.01 compared with control (100%)).
Yen et al. Arthritis Research & Therapy  (2015) 17:65 Page 7 of 13to MSU crystals (2 mg/ml) enhanced IL-1β secretion,
with a maximal increase at 36 h, while that of TGF-β1
had already occurred by 12 h. While TG2 deficiency re-
sulted in decreased MSU crystal-induced secretion of
TGF-β1, it enhanced that of IL-β (Figure 3B). These find-
ings indicate that TG2 might play a pivotal role in the
self-limitation of MSU crystal-induced pro-inflammatory
cytokine formation.Cross-linking activity of TG2 is required for promoting
and attenuating the MSU crystal-induced TGF-β1 and
IL-1β production, respectively
TG2 is a multifunctional protein. To decide whether its
protein cross-linking or other biological activities are
required for altering the MSU crystal-induced cytokine
formation, wild-type MEF cells were pretreated with or
without the cell-permeable TG2 active-site inhibitor
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MSU crystals for 4 h. As shown in Figure 3C, blockade of
TG2 cross-linking activity abolished TGF-β1 mRNA ex-
pression after MSU crystals stimulation. In harmony with
the mRNA results, pretreatment with ZDON also attenu-
ated the MSU crystal-induced TGF-β1 release, while it
promoted that of IL-1β (Figure 3D). These data indicate
that TG2 influences MSU crystal-induced cytokine release
by using its protein cross-linking activity.MSU crystal-induced TGF-β1 activity negatively regulates
MSU crystal-induced IL-1β production
To investigate whether the observed enhanced MSU
crystal-induced IL-1β production in TG2-null MEF cells
could be related to an inefficiently functioning TG2-
TGF-β1 pathway, we neutralized the activity of TGF-β1
by a pan TGF-β neutralizing antibody. Application of the
neutralizing antibody applied in concentrations of 0.5 to
5.0 μg/ml resulted in enhancement of MSU crystal-induced
IL-1β mRNA expression (Figure 3E and Additional file 2)
and IL-1β production (Figure 3F) in wild-type MEF cells
without affecting the MSU crystal-triggered TGF-β1
induction providing evidence for negative regulation of
MSU crystal-induced IL-1β production by the MSU
crystal-induced TGF-β1 signaling pathway.MTA1 is required for the MSU crystal-induced TG2 and
TGF-β1 expressions
As MTA1 is known to act as a co-regulator in the basal
and lipopolysaccharide-induced expression of TG2 in
macrophages [24], we decided to determine whether the
MTA1-TG2 axis is also involved in the negative feedback
regulation of MSU crystal-induced inflammation. First we
analyzed the alterations in MTA1 and TG2 mRNA ex-
pression in RAW264.7 cells stimulated with MSU crystals.
An early induction of MTA1 mRNA was observed in
RAW264.7 cells by 2 h in response to MSU crystals,
which preceded the induction of TG2 mRNA (Figure 4A).
To decide whether MTA1 contributes to MSU crystal-
induced TG2 expression, we performed knockdown of
MTA1 by siRNA in RAW264.7 cells (Figure 4B). Silen-
cing of MTA1 by specific siRNA in RAW264.7 cells
compromised the ability of MSU crystals to induce the
expression of TG2 and TGF-β1 mRNA and protein.
Conversely, the production of IL-1β and TNF-α was in-
creased (Figure 4B, C). To prove that the observed effects
of MTA1 silencing are indeed related to the prevention of
TG2 expression, recombinant TG2 was added to MTA1
knockdown cells. As shown in Figure 4D, addition of re-
combinant TG2 was able to correct the defect in TGF-β1
production leading to a decrease in the MSU-induced
IL-1β and TNF-α production in MTA1-silenced cells.
Our findings indicate that MTA1 offers protection againstMSU crystal-induced inflammation by directly enhancing
the TG2-dependent TGF-β1 signaling.Loss of TG2 enhances the MSU crystal-induced production
of IL-1β and decreases that of TGF-β1 in an in vivo
peritonitis model
To study the influence of TG2 on MSU crystal-induced
inflammation in vivo, MSU crystals were injected into the
peritoneum of wild-type and TG2-null mice [31] to exam-
ine the time-dependent cytokine formation and neutrophil
immigration following MSU crystal exposure. Injection of
3 mg MSU crystals into the peritoneum resulted in a bi-
phasic increase in both the IL-1β and in the active TGF-
β1 production, the first peak appearing at around 2 h,
while the second was at around 20 h following MSU crys-
tals injection. Loss of TG2 did not affect the early kinetics
of cytokine formation. However, as compared to the wild-
type animals, the second peak of TGF-β1 release was de-
layed in the TG2-null animals. In addition, the expression
of the pro-inflammatory cytokine IL-1β was increased,
while that of the anti-inflammatory cytokine TGF-β1 was
decreased in TG2-null mice (Figure 5A, B). Moreover, in
the peritoneal cavity of TG2-null animals a significantly
increased neutrophil number was detected upon treat-
ment, demonstrating the negative regulatory role of TG2
in the MSU crystal-induced inflammation also in the in-
tact organism (Figure 5C).Effects of TG2 overexpression and knockout on MSU
crystal-induced JAK2 phosphorylation
A recent study carried out in RAW264.7 macrophages indi-
cated that a JAK2-STAT3, JAK2-AKT-STAT3 pathway can
regulate IL-1β expression in these cells [34]. Thus, we de-
termined basal and MSU crystal-induced JAK2 (Tyr1007/
Tyr1008) phosphorylation levels to decide whether loss of
TG2 has any effect on it. As shown in Figure 6A and B,
increasing the level of TG2 in RAW264.7 macrophages de-
creased, while loss of TG2 in MEF cells increased the basal
level of phosphorylation of JAK2, which correlates with its
kinase activity. In addition, exposure to MSU crystals
increased the phosphorylation level of JAK2 in both mac-
rophages and MEF cells in a time-dependent manner
(Figure 6A, B).
To determine whether p-JAK2 participates in the
MSU crystal-induced IL-1β production, MEF cells were
pretreated with the JAK2-specific inhibitor AG490 for
60 minutes and then exposed to MSU crystals. As shown
in Figure 6C, the enhanced MSU crystal-induced IL-1β
production in TG2-null macrophages was completely di-
minished by AG490, while it only slightly attenuated the
MSU crystal-induced IL-1β production in wild-type cells.
In contrast, the TGF-β1 production was not affected by
JAK2 inhibition in any of the cells (Figure 6D) indicating
Figure 4 Effect of metastatic tumor antigen 1 (MTA1) knockdown on monosodium urate (MSU) crystal-induced cytokine production in
RAW264.7 cells. (A) Time course of the MSU crystal (1 mg/ml) induced increase in MTA1 and TG2 mRNA expression in RAW264.7 detected by
RT-PCR. Quantification of RT-PCR analysis of MTA1 and TG2 mRNA expressions is also shown. (B) RT-PCR analysis of RAW264.7 cells transfected
with MTA1 specific small interfering RNAs (siRNAs) for 48 h and stimulated then with or without MSU crystals (1 mg/ml) for 4 h. Quantification of
RT-PCR analysis of MTA1, TG2, TGF-β1, IL-1β and TNF-α mRNA expressions. (C) Cells were stimulated with or without MSU crystals (1 mg/ml) for
36 h. The levels of TGF-β1, IL-1β and TNF-α in supernatants were collected and evaluated by ELISA. (D) In addition, MTA1 knockdown
macrophages were also treated by MSU crystals (1 mg/ml) in the presence of recombinant TG2 (10 ng/ml) or IgG (10 ng/ml) for 36 h. The levels
of TGF-β1, IL-1β and TNF-α in supernatants were collected and evaluated by ELISA. The results are expressed as the means ± SEM from three
independent experiments (n≧ 3, * = P < 0.05, ** = P < 0.01 compared with control (100%)).
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was not mediated by regulation of TGF-β1 levels. As
shown in Figure 6E, administration of neutralizing TGF-
β1 antibodies enhanced the MSU crystal-induced IL-1β
production in wild-type MEFs, and this enhancement was
completely prevented by AG490, while administration of
neutralizing TGF-β antibodies did not affect the MSU
crystal-induced response of TG2 null MEFs. These data
provide evidence that TG2-induced TGF-β1 suppresses
the MSU crystal-induced IL-1β production by interfering
with the MSU crystal-induced JAK2 signaling pathway.Discussion
In this study, we provided evidence that TG2 contributes
to the limitation of inflammation in GA. We found that
TG2, as reported for IL-1β, TNF-α and TGF-β1 [15], is
expressed in higher levels in SFMCs of patients with
GA, and we observed that the protein is also highly
expressed in GA synovial tissues. In line with these obser-
vations, we found that exposure to MSU crystals induces
the expression of TG2 in human and mouse macrophages,
as well as in mouse fibroblasts. The mechanism of MSU
crystal-induced increase in TG2 expression in these cells
Figure 5 Effect of transglutaminase 2 (TG2) deficiency on monosodium urate (MSU) crystal-induced induced IL-1β and transforming
growth factor (TGF)-β1 production in vivo. Wild-type (WT) and TG2-deficient mice were injected intraperitoneally with 3 mg MSU crystals. Mice
were sacrificed at the indicated time points and peritoneal cells were obtained by lavage with 2 ml sterile PBS. (A, B) The levels of active TGF-β1
(A) and IL-1β (B) were determined at the indicated time points in the centrifuged, cell-free peritoneal lavage fluids, by ELISA. (C) The numbers of
Gr-1hi neutrophils in the peritoneum were analyzed by flow cytometry. The experiments were repeated three times. In each experiment three
mice were used at each time point. The results are expressed as the mean ± SEM from three independent experiments (n ≧3, *P <0.05
and **P <0.01).
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that similar to the lipopolysaccharide-induced increase in
TG2 expression in macrophages, it required the induction
of MTA1, a master co-activator acting on the chromatin.
Immune systems have evolved multiple strategies to
regulate and maintain an adequate level of inflammation,
including induction of negative feedback regulators for
inflammation. TGF-β1 [12] has been suggested to play
such a negative feedback regulatory role in gout by sup-
pressing MSU crystal-induced acute inflammation in vivo
[11,13]. In the present study we identified the MTA1-TG2
signaling pathway as a critical component for TGF-β1
production during MSU crystal-induced inflammation, as
both silencing of MTA1 and TG2 resulted in a lower
TGF-β1 production. TG2 very likely acts on the cell sur-
face in this process, because its loss could be compensated
by adding recombinant TG2 extracellularly to the cells. In
addition, induction of active TGF-β1 by TG2 requires the
cross-linking activity of the protein, because it was inhib-
ited by the highly specific active-site inhibitor, ZDON.
Interestingly, in a recent study it was also found that in-
creased expression of TG2 leads to enhanced TGF-β1
mRNA levels in fibroblasts [35]. Induction of TGF-β1mRNA by TG2 was a result of NF-κB activation, as the
TGF-β1 promoter consists in NF-κB response elements
[36]. Though in our studies the possible involvement of
NF-κB in the MSU crystal-induced, TG2-dependent TGF-
β1 induction was not investigated, it is worth noting that
TG2 is able to activate NF-κB in various cell types acting
either intra- or extracellularly. However, while intracellular
TG2 activates NF-κB through an IκBα degradation-
dependent mechanism [37], extracellular TG2 was re-
ported to trigger the non-canonical pathway of NF-κB
activation [38]. The receptors through which extracellu-
lar TG2 affects NF-κB activation have not been identi-
fied yet, but integrin receptors, for which TG2 acts as a
co-receptor are known to activate the non-canonical
NF-κB pathway [39].
We have also demonstrated that TGF-β1 induced by
MSU-crystal exposure negatively regulates MSU crystal-
induced pro-infammatory cytokine formation in macro-
phages, in a similar way as it does in MSU crystal-exposed
neutrophils [40]. Our data also indicate that it does so by
interfering with the MSU crystal-induced JAK2 signaling
pathway. Based on our data we propose that MSU crystals
trigger two independent signaling pathways in phagocytes,
Figure 6 Transglutaminase 2 (TG2) inhibits the basal and the monosodium urate (MSU) crystal-induced JAK2 activation. (A) RAW264.7
cells stably transfected with TG2 or empty vector (mock) were stimulated with or without MSU crystals (1 mg/ml) for the indicated time points.
Whole-cell lysates were analyzed by western blot analysis using antibodies against JAK2, phospho-JAK2 and β-actin. The ‘Fold’ induction was
measured by densitometry analysis and normalized to β-actin. (B) Wild-type and TG2 null MEF cells were treated for 1 h with or without MSU
crystals (2.0 mg/ml). Whole-cell lysates were analyzed by western blot analysis using antibodies against JAK2, phospho-JAK2 and β-actin. β-actin
was used as a loading control. The ‘Fold’ induction was measured by densitometry analysis and normalized to β-actin. (C-D) Wild-type and TG2
null MEF cells were treated for 36 h with or without MSU crystals (2.0 mg/ml) or in the presence of the JAK2 inhibitor (AG490). (C) IL-1β and (D)
TGF-β1 in the supernatants were evaluated by ELISA. (E) Experiments described in C were repeated in the presence of 0.5 g/ml neutralizing
anti-TGF-β antibody and its isotype control. The results are expressed as the means ± SEM from three independent experiments (n≧ 3, * = P < 0.05
compared with control (100%)).
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tion, and (2) the MTA1-TG2-TGF-β1 pathway, which
negatively regulates the first. Though the mechanism
through which this antagonism is mediated was not de-
termined in these studies, all together our data provide
evidence for the existence of an MTA1-regulated TG2-
TGF-β1 axis that might act as a negative feedback regu-
latory pathway in MSU crystal-induced inflammation.
To extend our studies we have also investigated the con-
sequence of the loss of TG2 on MSU crystal-induced IL-
1β and TGF-β1 formation in an in vivo mouse peritonitis
model by using TG2-null animals. We could confirm pre-
vious findings [27] that demonstrated that loss of TG2 en-
hances the number of neutrophils in the peritoneal cavity
following exposure to MSU crystals. However, unlike in
those studies, we found a significant difference in both the
MSU crystal-induced TGF-β1 and IL-1β production. In-
jection of MSU crystals into the peritoneum resulted in a
increase in both the IL-1β and in the active TGF-β1 re-
lease, but similar to the in vitro data the levels of active
TGF-β1 were higher, while that of IL-1β were lower in
wild-type mice as compared to TG2-null mice. As the loss
of TG2 was reported to also affect the efficiency of apop-
totic cell clearance [24-26], our data indicate that in vivo
TG2 might limit GA acting via several different simultan-
eous mechanisms including enhancing efferocytosis and
decreasing the production of pro-inflammatory cytokines.
Conclusions
In summary, we describe for the first time that MTA1 plays
an anti-inflammatory role in MSU crystal-induced inflam-
mation. We propose that in MSU crystal-induced inflam-
mation the MTA1-TG2 signaling pathway contributes to
the resolution of inflammation by enhancing TGF-β1 pro-
duction, which in turn attenuates MSU crystal-induced IL-
1β and TNF-α production. Our data indicate that TG2
plays a determining role in maintaining the balance in the
MSU crystal-induced pro- and anti-inflammatory cytokine
production, provide further evidence for the anti-
inflammatory role of TG2 in gout, and suggest that TG2
might have implications in the treatment of gouty arthritis.
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